NCT03470233View on ClinicalTrials.gov

Post Marketing Registry to Assess Usage, Safety and Effectiveness of Deltyba Tablets in Korean Patients With MDR-TB

CompletedOBSERVATIONAL
Enrollment

149

Participants

Timeline

Start Date

May 25, 2017

Primary Completion Date

June 21, 2021

Study Completion Date

June 21, 2021

Conditions
Multi-drug Resistant Tuberculosis
Trial Locations (2)

Unknown

Ulsan University Hospital, Ulsan

Pusan National University Yangsan Hospital, Yangsan

Sponsors
All Listed Sponsors
lead

Korea Otsuka Pharmaceutical Co., Ltd.

INDUSTRY